MPR

New Packaging Option for Narcan Nasal Spray Aims to Reduce Stigma

Narcan Nasal Spray is an opioid antagonist that reverses the effects of opioids, including respiratory depression, sedation, and hypotension.

Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving ...

Since the U.S. prescription launch of NARCAN® Nasal Spray in 2016, the medicine has been trusted as a safe, effective way to reverse opioid ...

Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa

GAITHERSBURG, Md. and PARIS and ADDIS ABABA, Ethiopia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced a ...
Under30CEO on MSN

How Epinal’s Narcolyzer addresses a growing emergent need for non-invasive, rapid, handheld narcotics testing

Public institutions across the world are reassessing how they identify and respond to narcotic impairment. Courts, ...
ZAWYA

Emergent BioSolutions, PANTHER Partner to Advance Africa Centres for Disease Control and Prevention (Africa CDC)-Led MpOx Study

Emergent BioSolutions, PANTHER Partner to Advance Africa Centres for Disease Control and Prevention (Africa CDC)-Led MpOx Study ...
ascopubs.org

Phase 1b study of tarlatamab in de novo or treatment-emergent neuroendocrine prostate cancer (NEPC).

ARV-766, a proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader, in metastatic castration-resistant prostate cancer (mCRPC): Initial results of a phase 1/2 study. Nivolumab and ...